Nocturnal Leg Cramps in Geneva : an Observational Study (CNMI)

May 18, 2018 updated by: Maisonneuve Hubert, University of Geneva, Switzerland

Prevalence, Main Features and Treatment of Nocturnal Leg Cramps in Geneva: A Primary Care Prospective Observational Study

Background :

Nocturnal leg cramps (NLC) are defined as painful involuntary contractions of the lower limbs occurring during prolonged periods of rest, typically during the night. They may cause severe pain and sleep disturbance, and are particularly common among older adults, though they can occur in all decades of life. They are frequently unreported to physicians. To the investigators' knowledge, no epidemiological studies have been conducted in Switzerland, but in a general population survey carried out in the UK (n=233), the overall prevalence of NLC was 37% and the disorder was more prevalent in older subjects (>80 years old: 54%). Of those who experienced NLC, 40% had cramps three or more times per week and 6% nightly. Another study performed in older US veterans (n=515) showed that 56% suffered from NLC.

The precise cause of these cramps is unclear. Most NLC occurring in adults appear to be idiopathic, but potential contributing factors include low levels of certain minerals, extracellular fluid volume depletion and prolonged sitting or inappropriate leg position during sedentary activity.

Research question :

What are the prevalence and the main features of NLC in patients consulting primary care physicians (PCPs) in Geneva, and how do PCPs treat this affection?

Primary objective :

To compute the prevalence of NLC in patients consulting PCPs in Geneva, explore its main features (number, duration, severity and sleep disturbance) and assess how PCPs treat this affection.

Study design :

Prospective observational study using questionnaire and daily log completed by patients.

Study Overview

Study Type

Observational

Enrollment (Actual)

129

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Geneva, Switzerland, 1211
        • Primary care network

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

50 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients of 50 years old or more, consulting primary care physicians in Geneva

Description

Inclusion Criteria:

  • Patients of 50 years old or more,
  • currently presenting NLC (The definition of NLC used for the purpose of the study is any cramp in the legs or feet, occurring during the sleep (eg long rest) period).
  • coming to the practice for a planned consultation.

Exclusion Criteria:

  • Patients suffering from a terminal illness
  • from disorders affecting their ability to consent,
  • not speaking French
  • or not having a telephone.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Ecologic or Community
  • Time Perspectives: Cross-Sectional

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Prevalence of NLC
Time Frame: Presence or absence of NLC will be checked during the time of recruitment for each participant PCP, with expected average of 1 to 6 months.
In order to compute the prevalence of NLC, the PCPs will be asked to specify for each patient coming for a planned consultation whether he/she has NLC, meets the inclusion criteria and accept to participate (group 1), has NLC, meets the inclusion criteria but refuses to participate (group 2) or has NLC but does not meet the inclusion criteria (group 3). For patients in the group 1 doctors will record the current date, the name and the first name, the gender, the date of birth and the phone number; for patients in the group 2 they will record the current date, the gender and the date of birth; and finally for patients in the group 3 they will record the current date, the gender, the date of birth and the exclusion criterion.
Presence or absence of NLC will be checked during the time of recruitment for each participant PCP, with expected average of 1 to 6 months.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Frequency of NLC
Time Frame: During two weeks after recruitment
Voluntaries will record during two weeks the number of cramps in a daily log.
During two weeks after recruitment
Duration of nocturnal leg cramps
Time Frame: During two weeks after recruitment
Voluntaries will record during two weeks the duration of cramps in a daily log.
During two weeks after recruitment
Severity of pain related with nocturnal leg cramps
Time Frame: During two weeks after recruitment
Voluntaries will record the severity of cramps in a daily log, standardized on an analog numerical scale of 1 to 10 .
During two weeks after recruitment
Severity of sleep disturbance related with nocturnal leg cramps
Time Frame: During two weeks after recruitment
Voluntaries will record the severity of sleep disturbance related with NLC, in a daily log, standardized on an analog numerical scale of 1 to 10.
During two weeks after recruitment
Patient expectancies for nocturnal leg cramps treatment
Time Frame: Two weeks after recruitment
We will ask the voluntaries to specify the average pain and sleep disturbance related with NLC on analog numerical scale of 1 to 10. We'll then ask them what improvement they would expect from a treatment on the same analog numeric scale for pain and sleep disturbance.
Two weeks after recruitment
Patient quality of life
Time Frame: 1 year after initial recruitment
Voluntaries will fill a SF36 questionnaire
1 year after initial recruitment
Patient quality of sleep
Time Frame: 1 year after initial recruitment
Voluntaries will fill a PSQI questionnaire
1 year after initial recruitment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Hubert Maisonneuve, MD, University of Genova

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2015

Primary Completion (Actual)

November 1, 2017

Study Completion (Actual)

April 1, 2018

Study Registration Dates

First Submitted

September 9, 2015

First Submitted That Met QC Criteria

September 10, 2015

First Posted (Estimate)

September 14, 2015

Study Record Updates

Last Update Posted (Actual)

May 22, 2018

Last Update Submitted That Met QC Criteria

May 18, 2018

Last Verified

May 1, 2018

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Nocturnal Leg Cramps

Clinical Trials on observational study, no intervention

Subscribe